Anti-tumor activity of a miR-199-dependent oncolytic adenovirus.
The down-regulation of miR-199 occurs in nearly all primary hepatocellular carcinomas (HCCs) and HCC cell lines in comparison with normal liver. We exploited this miR-199 differential expression to develop a conditionally replication-competent oncolytic adenovirus, Ad-199T, and achieve tumor-specifi...
Guardado en:
Autores principales: | Elisa Callegari, Bahaeldin K Elamin, Lucilla D'Abundo, Simonetta Falzoni, Giovanna Donvito, Farzaneh Moshiri, Maddalena Milazzo, Giuseppe Altavilla, Luciano Giacomelli, Francesca Fornari, Akseli Hemminki, Francesco Di Virgilio, Laura Gramantieri, Massimo Negrini, Silvia Sabbioni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e32ca045d1634705983595653fa456a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenoviruses.
por: Anna Kanerva, et al.
Publicado: (2008) -
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.
por: Laura Ahtiainen, et al.
Publicado: (2010) -
SPECT/CT imaging of hNIS-expression after intravenous delivery of an oncolytic adenovirus and 131I.
por: Maria Rajecki, et al.
Publicado: (2012) -
Acta Nº199
por: Banco Central de Chile
Publicado: (2019) - Oncolytic Virotherapy